Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Nisonic logo — The non-invasive method for detecting increased intracranial...

Nisonic

The non-invasive method for detecting increased intracranial pressure

Founded 2017 Norway Norway 1 employees Series Unknown Total: $16.00M Biotechnology, Health Care

General Information

Company Name Nisonic
Founded Year 2017
Location Norway Norway +1
Employees 1
Industries Biotechnology, Health Care
Funding Stage Series Unknown
Social

Get notified when Nisonic moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Nisonic

Nisonic is a Norwegian-based biotechnology startup that aims to revolutionize the measurement of intracranial pressure using advanced ultrasound technology. The company's non-invasive method provides a safe and cost-effective alternative to the current invasive procedure, which involves the insertion of a sensor into the cranium. This innovation holds significant promise for various medical conditions affecting intracranial pressure, including head trauma, stroke, meningitis, and brain tumors. The latest funding round in July 2018 saw kr16.00M investment from prominent backers such as Hadean Partners, Investinor, and SINTEF Venture AS. The company's commitment to offering a less intrusive approach to measuring intracranial pressure aligns with the growing demand for non-invasive medical technologies. Nisonic's pioneering solution has the potential to not only improve patient care but also disrupt the biotechnology and healthcare industries. With its innovative approach and strong financial backing, Nisonic is well-positioned to make a significant impact in the medical field.

Taxonomy: Medical Technology, Ultrasound Technology, Non-invasive Monitoring, ICP Monitoring, Intracranial Pressure, Traumatic Brain Injuries, Neurological Diseases, Healthcare Innovation, Emergency Medicine, Critical Care Units

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 3
Investor Investor
•••• •••• 		13 Jul 2018

Nisonic Alternatives & Competitors

Nisonic vs
SOPHYSA
SOPHYSA France

At the heart of the brain

171 employees
Medical Devices
Nisonic vs
VIC IT
VIC IT

VIC IT helps monitor symptoms of intracranial pressure with a smart, non-invasive solution.

Nisonic vs
BrainLink Health
BrainLink Health Sweden

More intelligent brain treatment.

6 employees

FAQ About Nisonic

The non-invasive method for detecting increased intracranial pressure
Nisonic was founded in 2017.
Nisonic is headquartered in Norway.
Nisonic operates in the following industries: Biotechnology, Health Care.
Nisonic has approximately 1 employees.
Nisonic has completed 1 funding round, raising a total of $16.00M. The latest funding stage is Series Unknown.
Top alternatives and competitors to Nisonic include SOPHYSA, VIC IT, BrainLink Health, BrainSpace, Rimed Ltd.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Nisonic and SOPHYSA are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Nisonic and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy